ABM Respiratory Care Receives the US FDA’s Clearance of Biwaze Clear System
Shots:
- The company received 510(k) clearance for its BiWaze clear system from the US FDA for acute & chronic respiratory conditions in the hospital, home & long-term care environments, also prevent bacterial & viral infections like COVID-19
- The new airway clearance system provides Oscillating lung expansion (OLE) therapy using a unique dual lumen breathing circuit to help patients clear their airways and prevent or treat atelectasis
- OLE therapy was found to decrease 31% of postoperative pulmonary complications and reduce the mean length of hospital stay by 1.6 days in a recent study with post-surgical patients. The system offers 3 therapies, incl. lung expansion, high-frequency oscillation, nebulization & Aerogen Solo
Ref: PR Newswire | Image: ABM Respiratory Care
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
